In California, researchers at University of California San Diego School of Medicine and Shiley Eye Institute at UC San Diego Health, with colleagues in China, used the gene-editing tool, CRISPR, to reprogram mutated rod photoreceptors and restoring vision in two mouse models. Retinitis pigmentosa is an inherited vision disorder resulting from genetic mutation in more than 60 genes making it difficult for night vision, peripheral vision, color discernment and central vision. It affects about 1 in 4,000 people globally with the eventual result possibly becoming legal blindness and there is no current treatment for it. The ability of researchers to shut off or deactivate certain gene “switches” allowed them to modify select genes to restore vision. They hope to perform clinical trials on humans soon since there is no other treatment or cure for retinitis pigmentosa currently.
Latest article
New yoga fabric collection from Hyosung TNC and Lenzing “nama-stays” away from synthetic fibers
In South Korea, global elastane leader Hyosung TNC and Lenzing Group, a leading global producer of regenerated cellulosic fibers for the textile and nonwovens...
Egg carton kicks explore intersection of design and simplicity
In Prague, Kibardin Design has created a sneaker concept out of recycled egg cartons. Dubbed Egg Box Sneakers, the design project combines art, fashion...
Oyster waste provides pleasant “shell-ter” for Sydney parkgoers
In Sydney, Australia, a new Pier Pavilion designed by Besley & Spresser has been built using waste rock oyster shells.
Comprising a “striking landscape...